Weight loss drugs are compared for effectivenessBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3330 (Published 15 June 2016) Cite this as: BMJ 2016;353:i3330
- Jacqui Wise
The obesity drug phentermine-topiramate was associated with the highest odds of achieving weight loss of at least 5% when compared with four other agents, a meta-analysis and systematic review published in JAMA has found.1
The review found that five weight loss drugs, when compared with placebo, were each associated with achieving at least 5% weight loss after a year in overweight or obese adults. The five drugs—orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide—have all been approved by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial